基于对比增强乳腺X线的瘤内及瘤周影像组学术前预测乳腺癌腋窝非前哨淋巴结转移:多中心研究
本研究纳入365例伴前哨淋巴结转移的乳腺癌患者,基于对比增强乳腺X线(CEM)提取瘤内及瘤周(5、10 mm)影像组学特征,构建支持向量机模型预测非前哨淋巴结(NSLN)转移。瘤内+瘤周10 mm模型在内外部测试集AUC分别为0.8000和0.7567,外部测试集AUC高于MSKCC模型(0.6681),但差异无统计学意义(p=0.361)。结论认为该模型可作为辅助工具帮助制定手术方案。
要点
- 瘤内联合瘤周10 mm的CEM影像组学模型预测NSLN转移的外部测试AUC为0.7567。
- 该模型外部测试AUC高于MSKCC模型(0.6681),但差异无统计学意义(p=0.361)。
- 瘤内ROI需手动勾画,瘤周ROI(5、10 mm)自动获得,基于CEM图像。
核心结论
- 基于CEM的瘤内及瘤周影像组学模型对乳腺癌NSLN转移具有可接受的预测性能,可作为辅助预测工具帮助临床制定合适的手术方案。
研究设计与样本
- 多中心研究,纳入365例伴前哨淋巴结转移的乳腺癌患者。
- 手动勾画瘤内ROI,自动获取瘤周5 mm和10 mm ROI。
- 采用支持向量机分类器,基于方差阈值、SelectKbest和LASSO算法筛选最优特征,构建5种模型(瘤内、瘤周5 mm、瘤周10 mm、瘤内+瘤周5 mm、瘤内+瘤周10 mm)。
- 使用ROC曲线评估预测性能,并设置外部测试集验证模型。
- 以MSKCC模型作为对比,比较影像组学模型的预测性能。
诊断标准与关键数值
- 瘤内ROI及瘤内+瘤周10 mm ROI影像组学模型在内外部测试集中表现最佳,内部测试集AUC为0.8000(95%CI:0.6871-0.8266)。
- 外部测试集中影像组学模型AUC为0.7567(95%CI:0.6717-0.8678),高于MSKCC模型(AUC=0.6681,95%CI:0.5148-0.8213),p=0.361。
临床应用与阅片要点
- 对于伴前哨淋巴结转移的乳腺癌患者,可考虑使用基于CEM的瘤内+瘤周10 mm影像组学模型无创预测NSLN转移,辅助手术决策。
- 模型预测性能为可接受水平,外部测试AUC未显著优于MSKCC模型,应结合临床其他信息综合判断。
局限性
- 外部测试集AUC与MSKCC模型比较差异无统计学意义(p=0.361),需进一步验证。
- 瘤内ROI为手动勾画,可能引入主观差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop and test a contrast-enhanced mammography (CEM)-based radiomics model using intratumoral and peritumoral regions to predict non-sentinel lymph node (NSLN) metastasis in breast cancer before surgery.
METHODS: This multicenter study included 365 breast cancer patients with sentinel lymph node metastasis. Intratumoral regions of interest (ROIs) were manually delineated, and peritumoral ROIs (5 and 10 mm) were automatically obtained. Five models, including intratumoral model, peritumoral (5 and 10 mm) models, and intratumoral+peritumoral (5 and 10 mm) models, were constructed by support vector machine classifier on the basis of optimal features selected by variance threshold, SelectKbest, and least absolute shrinkage and selection operator algorithms. The predictive performance of radiomics models was evaluated by receiver operating characteristic curves. An external testing set was used to test the model. The Memorial Sloan Kettering Cancer Center (MSKCC) model was used to compare the predictive performance with radiomics model.
RESULTS: The intratumoral ROI and intratumoral+peritumoral 10-mm ROI-based radiomics model achieved the best performance with an area under the curve (AUC) of 0.8000 (95% confidence interval [CI]: 0.6871-0.8266) in the internal testing set. In the external testing set, the AUC of radiomics model was 0.7567 (95% CI: 0.6717-0.8678), higher than that of MSKCC model (AUC = 0.6681, 95% CI: 0.5148-0.8213) (p = 0.361).
CONCLUSIONS: The intratumoral and peritumoral radiomics based on CEM had an acceptable predictive performance in predicting NSLN metastasis in breast cancer, which could be seen as a supplementary predicting tool to help clinicians make appropriate surgical plans.
ADVANCES IN KNOWLEDGE: The intratumoral and peritumoral CEM-based radiomics model could noninvasively predict NSLN metastasis in breast cancer patients before surgery.
引用
- Lin, Li, Wang, et al. Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study. Br J Radiol. 2023. PMID: 36542866. doi:10.1259/bjr.20220068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。